Comments
Glenmark on Thursday said it has opened its new facility in Argentina which would serve as a global hub for cancer treatment drugs.
The facility, in the outskirts of Argentine capital Buenos Aires, was jointly inaugurated yesterday by Minister of State for Commerce & Industry Mr Jyotiraditya Scindia and Argentina Minister of Industry Mr Debora Giorgi, the company said in a statement.
The oncology manufacturing facility will serve as Glenmark’s global hub for manufacturing products used for treatment of cancer.
The new plant has an initial manufacturing capacity of one million units of liquids and around 1.3 million units of lyophilized concentrates and would be able to service the requirements of about 75 per cent of cancer therapy products, it said.
Commenting on the development Glenmark Generics Limited President Mr Jalaj Sharma said: “Glenmark’s strategic intent is to emerge as a formidable player in the global oncology segment and this facility will serve as the global hub of oncology products for the entire organisation“.
Glenmark had acquired Argentina’s oncology firm, Servycal S A in 2005 and helped it establish as an important player in oncology segment in the Latin and Central America region.
Besides operations in Argentina, Glenmark has operations in 12 other markets in the Latin America region and currently over 250 products are sold in this region.
Shares of Glenmark closed at Rs 277.55 on the Bombay Stock Exchange, down 4.92 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.